
Sign up to save your podcasts
Or


Larry Hamann, co-founder, president, and CEO of Interdict Bio, speaks with Venrock Vice President Mariana Mihalusova about lessons learned from his career in drug discovery. Hamann delves into where his love for organic chemistry stems from and why inclusive environments are essential to building successful teams. He also speaks about the do's and don'ts when structuring collaborations with big pharma, when a drug is "good enough" to move forward in development and new approaches he's excited for.
By Venrock, a venture capital firm4.8
6262 ratings
Larry Hamann, co-founder, president, and CEO of Interdict Bio, speaks with Venrock Vice President Mariana Mihalusova about lessons learned from his career in drug discovery. Hamann delves into where his love for organic chemistry stems from and why inclusive environments are essential to building successful teams. He also speaks about the do's and don'ts when structuring collaborations with big pharma, when a drug is "good enough" to move forward in development and new approaches he's excited for.

1,290 Listeners

2,671 Listeners

2,444 Listeners

1,100 Listeners

341 Listeners

324 Listeners

396 Listeners

5,522 Listeners

9,902 Listeners

34 Listeners

506 Listeners

19 Listeners

265 Listeners

521 Listeners

1,356 Listeners